日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Improving the health of the drugs industry

By Liu Jie | China Daily | Updated: 2013-04-11 10:28

Improving the health of the drugs industry

An employee at Eli Lilly and Co's China Research and Development Center. The US-based international drugmaker puts 20 percent of its sales revenue into R&D every year and set up an R&D center in Shanghai last May. [Provided to China Daily]


Eli Lilly chief Lechleiter sees China as the company's most promising market

John C. Lechleiter says he loves work and believes everyone has to find his or her own right answer about a work-life balance.

"I find it's very difficult to separate them out: That is work and this is life," said the chairman, president and chief executive officer of the world's fifth-largest biopharmaceutical company Eli Lilly and Co.

With a very supportive wife, Lechleiter said he is very conscious about getting enough sleep at night and tries to get regular exercise. All of these are because, as he said: "I try to make sure that when I need to work hard, I am able to do that."

In addition to being CEO of Lilly, he also works for industrial associations - as chairman of the Pharmaceutical Research and Manufacturers of America and president of the International Federation of Pharmaceutical Manufacturers & Associations - and on the boards of many institutes, such as the Life Sciences Foundation and the Central Indiana Corporate Partnership. Taking multiple roles, none of them easy, means Lechleiter's life is full of meetings, conferences, forums and business trips.

Challenging works

Like many innovative drug producers, Lilly has faced a tough time since 2011, with patents of the company's several blockbuster drugs expiring, leading to generic drugs sold at much lower prices booming in the market. Meanwhile, the development of new medicines has not been completed. That's a crucial threat to any pharmaceutical company that relies on research and development.

"Lilly has been clear from the very beginning: We intend to invest properly in R&D and really depend on our pipeline to help resume growth after this period (of patent expiration)," said Lechleiter, adding that the drugmaker will continue to put 20 percent of its sales revenue into R&D.

He also marked up developing and emerging markets, including China, and exploring the wider potential of current products as part of a strategy to lift the company out of these hard times.

Previous Page 1 2 3 4 5 6 Next Page

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 天天影视插插插 | 免费能直接在线观看黄的视频 | 亚洲精品色综合久久 | 国产免费久久精品44 | 毛片免费观看视频 | 视频精品一区 | 日日摸夜夜摸狠狠摸日日碰夜夜做 | 色噜噜视频 | 91视频精选 | 日本小网站 | 人人干人人干人人干 | 久久综合久色欧美综合狠狠 | 亚洲激情综合 | 天堂在线免费视频 | 欧日韩不卡在线视频 | 一区免费看 | 亚洲成人另类 | 天天爱天天爽 | www.av视频 | 亚洲欧美日韩在线一区 | 国产成人精品免高潮在线观看 | 一区二区视频 | 亚洲在线观看免费视频 | 99re国产| 91www成人久久 | 任我爽在线视频 | 五月天亚洲综合 | 碰碰碰人人澡人人爱摸 | 精品国产乱码久久久久久丨区2区 | 亚洲欧美中文日韩在线v日本 | 亚洲午夜在线播放 | www.日韩| A片扒开双腿进入做视频 | 天天干影视| 日本一区二区视频在线 | 亚洲a网 | 欧美一级毛片在线看视频 | 日韩视频不卡 | 日韩中文欧美 | 久久久中文 | 亚洲依依成人综合网站 |